348 related articles for article (PubMed ID: 33299643)
1. Radiotherapy in combination with systemic therapies for brain metastases: current status and progress.
Liu L; Chen W; Zhang R; Wang Y; Liu P; Lian X; Zhang F; Wang Y; Ma W
Cancer Biol Med; 2020 Nov; 17(4):910-922. PubMed ID: 33299643
[TBL] [Abstract][Full Text] [Related]
2. Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov.
Tini P; Marampon F; Giraffa M; Bucelli S; Niyazi M; Belka C; Minniti G
Radiat Oncol; 2023 Apr; 18(1):62. PubMed ID: 37016421
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous.
Nieder C; Guckenberger M; Gaspar LE; Rusthoven CG; De Ruysscher D; Sahgal A; Nguyen T; Grosu AL; Mehta MP
Radiat Oncol; 2019 Feb; 14(1):33. PubMed ID: 30770745
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
5. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
6. Targeted and immunotherapeutic approaches in brain metastases.
Ahluwalia MS; Winkler F
Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144
[TBL] [Abstract][Full Text] [Related]
7. The role of whole brain radiation therapy for the management of brain metastases in the era of stereotactic radiosurgery.
Abe E; Aoyama H
Curr Oncol Rep; 2012 Feb; 14(1):79-84. PubMed ID: 22006098
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: A meta-analysis (PRISMA) of randomized control trials.
Qie S; Li Y; Shi HY; Yuan L; Su L; Zhang X
Medicine (Baltimore); 2018 Aug; 97(33):e11777. PubMed ID: 30113464
[TBL] [Abstract][Full Text] [Related]
10. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
11. Management of Brain Metastases in Non-Small-Cell Lung Cancer.
Ernani V; Stinchcombe TE
J Oncol Pract; 2019 Nov; 15(11):563-570. PubMed ID: 31715122
[TBL] [Abstract][Full Text] [Related]
12. Whole Brain Radiotherapy Combined with Stereotactic Radiosurgery versus Stereotactic Radiosurgery Alone for Brain Metastases.
Adas YG; Yazici O; Kekilli E; Akkas EA; Karakaya E; Ucer AR; Ertas G; Calikoglu T; Elgin Y; Inan GA; Kocer AM; Guney Y
Asian Pac J Cancer Prev; 2015; 16(17):7595-7. PubMed ID: 26625767
[TBL] [Abstract][Full Text] [Related]
13. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer.
Churilla TM; Weiss SE
Curr Oncol Rep; 2018 May; 20(7):54. PubMed ID: 29736685
[TBL] [Abstract][Full Text] [Related]
14. Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS; Patel PR; Curran WJ; Shu HG; Sica GL; Higgins KA
Cancer; 2018 Sep; 124(17):3586-3595. PubMed ID: 30120912
[TBL] [Abstract][Full Text] [Related]
15. Recent trends of characteristics and treatments in adults with newly diagnosed brain metastases.
Koide Y; Nagai N; Miyauchi R; Kitagawa T; Aoyama T; Shimizu H; Hashimoto S; Tachibana H; Kodaira T
Jpn J Clin Oncol; 2023 Jun; 53(7):572-580. PubMed ID: 37002189
[TBL] [Abstract][Full Text] [Related]
16. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
[TBL] [Abstract][Full Text] [Related]
17. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
[TBL] [Abstract][Full Text] [Related]
19. [Melanoma brain metastases : Treatment options].
Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
[TBL] [Abstract][Full Text] [Related]
20. Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases.
Moyers JT; Chong EG; Peng J; Tsai HHC; Sufficool D; Shavlik D; Nagaraj G
Cancer Med; 2021 Feb; 10(4):1201-1211. PubMed ID: 33484100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
